Steven Lichtman
Stock Analyst at William Blair
(4.79)
# 563
Out of 5,090 analysts
1013
Total ratings
53.1%
Success rate
14.6%
Average return
Main Sectors:
Stocks Rated by Steven Lichtman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OWLT Owlet | Reiterated: Buy | n/a | $4.05 | - | 2 | Sep 25, 2026 | |
| BFLY Butterfly Network | Reiterated: Buy | n/a | $6.39 | - | 2 | Sep 15, 2026 | |
| BBNX Beta Bionics | Reiterated: Hold | n/a | $16.75 | - | 2 | Sep 14, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | n/a | $18.28 | - | 5 | Sep 14, 2026 | |
| COO The Cooper Companies | Downgraded: Hold | n/a | $59.55 | - | 32 | Sep 12, 2026 | |
| SYK Stryker | Reiterated: Buy | n/a | $291.86 | - | 54 | Sep 9, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Buy | n/a | $19.11 | - | 44 | Aug 21, 2026 | |
| ENOV Enovis | Reiterated: Buy | n/a | $19.91 | - | 3 | Aug 14, 2026 | |
| SWX: ALC Alcon Inc. | Rated: Hold | n/a | $59.10 | - | 8 | Aug 12, 2026 | |
| RXST RxSight | Reiterated: Hold | n/a | $4.87 | - | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.32 | - | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $94.52 | - | 73 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $149.68 | - | 65 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $82.29 | - | 90 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $237.60 | - | 16 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $15 | $3.50 | n/a | 22 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $118 | $41.98 | n/a | 81 | Aug 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $7.5 | $11.36 | n/a | 22 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $73 → $78 | $78.05 | n/a | 69 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $87 → $116 | $86.24 | n/a | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $16 | $11.99 | n/a | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $275 | $318.95 | n/a | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $24.54 | n/a | 5 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $92 → $94 | $96.54 | n/a | 146 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.75 | n/a | 123 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $1.72 | n/a | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0109 | n/a | 17 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.7681 | n/a | 15 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.09 | n/a | 8 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.95 | n/a | 13 | Dec 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 | $298.23 | n/a | 1 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.98 | n/a | 11 | May 27, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.68 | n/a | 26 | Mar 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.45 | n/a | 13 | Mar 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.8626 | n/a | 1 | Oct 7, 2011 |
Owlet
Sep 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.05
Upside: -
Butterfly Network
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.39
Upside: -
Beta Bionics
Sep 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $16.75
Upside: -
MiniMed Group
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.28
Upside: -
The Cooper Companies
Sep 12, 2026
Downgraded: Hold
Price Target: n/a
Current: $59.55
Upside: -
Stryker
Sep 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $291.86
Upside: -
Tandem Diabetes Care
Aug 21, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $19.11
Upside: -
Enovis
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.91
Upside: -
Alcon Inc.
Aug 12, 2026
Rated: Hold
Price Target: n/a
Current: $59.10
Upside: -
RxSight
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.87
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.32
Upside: -
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $94.52
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $149.68
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $82.29
Upside: -
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $237.60
Upside: -
Sep 5, 2025
Reiterated: Buy
Price Target: $12 → $15
Current: $3.50
Upside: n/a
Aug 3, 2025
Reiterated: Hold
Price Target: $118
Current: $41.98
Upside: n/a
May 14, 2025
Reiterated: Buy
Price Target: $11 → $7.5
Current: $11.36
Upside: n/a
May 9, 2025
Reiterated: Hold
Price Target: $73 → $78
Current: $78.05
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: $87 → $116
Current: $86.24
Upside: n/a
Jan 10, 2025
Reiterated: Buy
Price Target: $13 → $16
Current: $11.99
Upside: n/a
Dec 16, 2024
Initiated Coverage: Buy
Price Target: $275
Current: $318.95
Upside: n/a
Nov 1, 2024
Reiterated: Hold
Price Target: n/a
Current: $24.54
Upside: n/a
Aug 21, 2024
Reiterated: Hold
Price Target: $92 → $94
Current: $96.54
Upside: n/a
May 7, 2024
Downgraded: Hold
Price Target: n/a
Current: $12.75
Upside: n/a
Sep 19, 2023
Reiterated: Buy
Price Target: $3.5
Current: $1.72
Upside: n/a
Feb 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0109
Upside: n/a
Aug 10, 2022
Downgraded: Hold
Price Target: n/a
Current: $0.7681
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $2.09
Upside: n/a
Dec 18, 2018
Rated: Hold
Price Target: n/a
Current: $5.95
Upside: n/a
Feb 8, 2018
Reiterated: Buy
Price Target: $237
Current: $298.23
Upside: n/a
May 27, 2016
Reiterated: Hold
Price Target: n/a
Current: $2.98
Upside: n/a
Mar 4, 2016
Downgraded: Hold
Price Target: n/a
Current: $5.68
Upside: n/a
Mar 13, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.45
Upside: n/a
Oct 7, 2011
Downgraded: Hold
Price Target: n/a
Current: $0.8626
Upside: n/a